HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Jo Hansford Color Maintenance Line Diversifies Lamaur Portfolio

This article was originally published in The Rose Sheet

Executive Summary

Lamaur will bring British hair care brand Jo Hansford to the U.S. mass market in first quarter 2002 under the first in a series of distribution agreements with international beauty manufacturers, CEO Lawrence Pesin said.

You may also be interested in...



Lamaur Licensing Agreements Represent New Growth Channels

Hair care manufacturer Lamaur plans to sign a number of exclusive licensing agreements during the upcoming year to drive business in new, uncharted directions, as the Fridley, Minn. company continues to rebuild a struggling business.

Lamaur

Willow Lake, Salon Style, Design Elements and Style hair care brands to be distributed in Eastern Europe under agreement with Moscow-based personal care distributor Vision Plus, the Minneapolis company announces Nov. 7. Expansion is part of Lamaur's "three-pronged" growth strategy to increase sales, profits and shareholder value, firm says. Lamaur CEO Larry Pesin and board member Harold Copperman initiated the alliance; Copperman will oversee international initiatives, Lamaur notes

OCA Applauds Organic Board's Recommendation To USDA: "Outlaw Nanotech"

With a push from the Organic Consumers Association, the National Organic Standards Board is recommending that the use of nanotechnology be strictly prohibited from products certified under the National Organic Program

Latest Headlines
See All
UsernamePublicRestriction

Register

RS009427

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel